An emerging immunotherapy treatment, chimeric antigen receptor (CAR) T-cell therapy can be very effective in treating patients with B-cell malignancies. However, knowledge gaps exist over the role of CAR T-cell therapy in the management of these patients. In an effort to close these gaps, i3 Health provided an NCPD-approved online strategy session titled Understanding and Optimizing CAR T-Cell Therapy for Patients With B-Cell Malignancies.A total of 539 participants completed this activity, incl...
By accepting you will be accessing a service provided by a third-party external to https://i3health.net/
The increased prevalence of technology in today's society has opened up numerous windows for alternative methods of continuing medical education (CME). However, according to a survey conducted by i3 Health at the 67th Society of Government Service Urologists (SGSU) Kimbrough Urological Seminar held in Charlotte, North Carolina, in January 2020, live meetings still remain the preferred CME format among urologists.Surveys were completed by 36 individuals, of whom 35 (97.2%) were physicians and oth...
Carcinoid syndrome occurs when carcinoid tumors secrete serotonin or other chemicals into the bloodstream. Because primary symptoms of carcinoid syndrome are associated with other more common diseases, timely recognition is difficult, negatively impacting patients' quality of life and functioning. A CNE-approved Oncology Nursing Strategy Session, Optimizing Management of Carcinoid Syndrome in Patients With Neuroendocrine Tumors, revealed meaningful improvements in nurses' knowledge surrounding r...
With the substantial expansion of treatment options for castration-resistant prostate cancer (CRPC), including novel hormone therapies, second-generation taxanes, immunotherapy, and bone metastasis-targeted agents, there is a significant need for continuing medical education (CME) to ensure that physicians remain well informed as they seek to optimize treatment for their patients. Assessment data from i3 Health's CME-approved satellite symposium, Castration-Resistant Prostate Cancer: Implementin...
i3 Health's surveys of oncology nurses at the Oncology Nursing Society (ONS) 44th Annual Congress in Anaheim, California, in April 2019 revealed respondents' preferred formats for continuing nursing education (CNE) activities.The surveys focused on educational needs concerning immune checkpoint inhibitors, cyclin-dependent kinase (CDK)4/6 inhibitors, chimeric antigen receptor (CAR) T-cell therapy, poly (ADP)-ribose polymerase (PARP) inhibitors, and biosimilars. Surveys were completed by 304 onco...